CMMB insider trading

NasdaqCM Healthcare

Chemomab Therapeutics Ltd.: insider trade history from SEC Form 4 filings.

Total Form 4 trades
35
Last 90 days
2
Buys / sells
66% / 26%
Market cap
$14.40M

About Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases. Its lead product candidate is nebokitug, a humanized monoclonal antibody that attenuates the basic function of CCL24 as a regulator of major inflammatory and fibrotic pathways, which has completed phase 2 clinical trial for treating primary sclerosing cholangitis, as well as in phase 2 clinical trial to treat systemic sclerosis. The company was founded in 2011 and is based in Tel Aviv-Yafo, Israel.

Company website: www.chemomab.com

CMMB insider activity at a glance

FilingIQ tracks 35 insider transactions for CMMB in filings since Mar 18, 2021. The most recent transaction is dated Aug 28, 2026.

Across the full history, 23 open-market purchases and 9 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.

Latest CMMB Form 4 filings

Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for CMMB?
FilingIQ tracks 35 Form 4 insider transactions for CMMB (Chemomab Therapeutics Ltd.), covering filings from Mar 18, 2021 onwards. 2 of those are dated within the last 90 days.
Are CMMB insiders net buyers or net sellers?
Across the full Form 4 history for CMMB, 23 transactions (66%) were open-market purchases and 9 (26%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CMMB insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
What sector is CMMB in?
Chemomab Therapeutics Ltd. (CMMB) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $14.40M.

Methodology & sources

Every CMMB insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.